News: 2016

Monica Healthcare is a winner in the 2016 Premier Inc Innovation Celebrations

GE Healthcare on behalf of Monica Healthcare showcased the Monica Novii Wireless Patch System at Premier Inc.’s 2016 annual Breakthroughs Conference. Monica’s Novii System is one of the medical innovations that was showcased in front of thousands of healthcare...

Catapult Ventures appoints Dr David Whitcombe as Venture Partner

Catapult Ventures has announced that Dr David Whitcombe has become a Venture Partner with its new GM&C Life Sciences Fund. Dr Whitcombe, who has worked alongside Catapult and its portfolio companies for a number of years informally, is best known as a co-founder of DxS...

Probe Scientific in top disruptive medical technologies index

British early stage medical device and diagnostic company, Probe Scientific Ltd has been named one of the world’s most influential companies on the Disrupt 100 index which lists “companies shaping our futures”. The largest sector for disruption is Health Tech...

Catapult Ventures sells Haemostatix to Ergomed

Catapult Ventures has completed the sale of its stake in Haemostatix Limited (‘Haemostatix’) to Ergomed plc (‘Ergomed’). Ergomed is acquiring 100 per cent of the issued share capital of Haemostatix for an initial consideration of £8.0 million, with...

Three weeks: Four trophies: One BWB!

BWB’s commitment to the next generation of engineering talent has secured national recognition from one of the industry’s most influential organisations – and a remarkable awards double! ACE – the Association for Consultancy and Engineering – held...

Yospace wins at Mediatel’s Connected Consumer Awards

Yospace is delighted to have won in the Connected Content Service of the Year category of Mediatel’s prestigious Connected Consumer Awards. The category recognizes innovations such as new advertising models and formats and was awarded to Yospace for its work with Channel 4...

Blueberry Therapeutics raises £3m led by GM&C Life Sciences Fund

Alderley Park, Cheshire, UK - 5th May 2016. Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund...

Yospace Wins NewBay Media’s Best of Show Award, Presented by TV Technology

Yospace is delighted to have won NewBay Media’s Best of Show Award, presented at the 2016 NAB Show in Las Vegas by TV Technology. The award recognises the importance of Yospace’s Dynamic Ad Insertion platform in enabling live channels to be monetised when viewed...

Catapult exits Food and Drug Analytical Services

Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates

Oxford BioTherapeutics (OBT), a company developing a range of innovative Antibody Drug Conjugates (ADCs) for the treatment of cancer and Nerviano Medical Sciences (Nerviano), a company of the NMS Group dedicated to the discovery and development of breakthrough treatments for...